Firefly Neuroscience (AIFF) Receivables (2010 - 2026)

Firefly Neuroscience has reported Receivables for 17 years, with the latest figure at $248000.0 in Q2 2026.

• On a quarterly basis, Receivables fell 37.53% year-over-year to $248000.0 in Q2 2026; TTM through Jun 2026 was $248000.0, a 37.53% decrease from a year earlier, with the FY2025 full-year figure at $274000.0, down 22.6% from the prior year.
• Receivables was $248000.0 for Q2 2026 at Firefly Neuroscience, down from $263000.0 in the prior quarter.
• The five-year high for Receivables was $3.6 million in Q2 2022, with the low at $100000.0 in Q1 2025.
• Average Receivables over 5 years is $833746.2, with a median of $379000.0 recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Receivables plunged 92.4% in 2023, then jumped 510.61% in 2024.
• Over 5 years, Receivables stood at $182756.0 in 2022, then jumped by 53.21% to $280000.0 in 2023, then increased by 26.43% to $354000.0 in 2024, then declined by 22.6% to $274000.0 in 2025, then dropped by 9.49% to $248000.0 in 2026.
• The last three Receivables figures came in at $248000.0 (Q2 2026), $263000.0 (Q1 2026), and $274000.0 (Q4 2025), per Business Quant data.